Swedish Orphan Biovitrum
SOBI.ST
#1839
Rank
$8.48 B
Marketcap
$24.99
Share price
-1.84%
Change (1 day)
6.39%
Change (1 year)

P/E ratio for Swedish Orphan Biovitrum (SOBI.ST)

P/E ratio as of March 2024 (TTM): 36.7

According to Swedish Orphan Biovitrum's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 36.683. At the end of 2022 the company had a P/E ratio of 31.4.

P/E ratio history for Swedish Orphan Biovitrum from 2009 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202231.450.57%
202120.935.12%
202015.510.17%
201914.0-39.53%
201823.2-14.48%
201727.1-25.34%
201636.3-93.87%
2015593-808.97%
2014-83.6-57.83%
2013-198108.71%
2012-95.0-169.08%
2011138-284.05%
2010-74.7-186.12%
200986.8

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.